This Article Full Text Full Text (PDF) All Versions of this Article: 108/9/1133    most recent 01.CIR.0000086469.85750.48v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmitt, J. P. Articles by Seidman, J.G. Search for Related Content PubMed PubMed Citation Articles by Schmitt, J. P. Articles by Seidman, J.G. Related Collections Animal models of human disease Hypertrophy Myocardial cardiomyopathy disease Genetics of cardiovascular disease

(Circulation. 2003;108:1133.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Consequences of Pressure Overload on Sarcomere Protein Mutation-Induced Hypertrophic Cardiomyopathy

Joachim P. Schmitt, MD^*; Christopher Semsarian, MD, PhD^*; Michael Arad, MD; Joseph Gannon, BS; Ferhaan Ahmad, MD, PhD; Catherine Duffy, BS; Richard T. Lee, MD; Christine E. Seidman, MD; J.G. Seidman, PhD

From the Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute (J.P.S., C.S., M.A., F.A., C.D., C.E.S., J.G.S.), and Cardiovascular Division (J.G., R.T.L.) and Division of Cardiology (C.E.S.), Brigham and Women’s Hospital, Boston, Mass.

Correspondence to Dr J.G. Seidman, PhD, Department of Genetics, Harvard Medical School, 200 Longwood Ave, Boston, MA 02115. E-mail seidman{at}rascal.med.harvard.edu

Received April 2, 2002; de novo received March 12, 2003; revision received April 29, 2003; accepted May 9, 2003.

Background— Whether ventricular remodeling from hypertrophic cardiomyopathy (HCM), systemic hypertension, or other pathologies arises through a common signaling pathway or through independent molecular mechanisms is unknown. To study this, we assessed cardiac hypertrophy in a mouse model of HCM subjected to increased left ventricular (LV) load.

Methods and Results— Transverse aortic banding of mice with or without an Arg403Gln cardiac myosin heavy chain mutation (MHC^403/+) produced similarly elevated LV pressures (120±30 versus 112±14 mm Hg; P=NS). No mice developed heart failure, and mortality (26% MHC^403/+, 35% wild-type) was comparable. Load-induced hypertrophy was identical in banded 129SvEv MHC^403/+ mice (LV anterior wall [LVAW]=1.28±0.11) and 129SvEv wild-type mice (LVAW=1.29±0.11 mm; P=NS). Genetically outbred Black Swiss (BS) MHC^403/+ mice showed only mildly exaggerated hypertrophy in response to aortic banding (BS MHC^403/+ LVAW=1.30±0.13 mm; BS wild-type LVAW=1.17±0.15 mm; P=0.03), suggesting some effect from a BS genetic locus that modifies hypertrophy induced by the cardiac MHC Arg403Gln mutation. Histopathology and molecular markers of hypertrophy were comparable in all banded 129SvEv or BS mice. Banded MHC^403/+ mice had potential for greater hypertrophy, because cyclosporin A treatment markedly augmented hypertrophy.

Conclusions— The uniform hypertrophic response to increased ventricular load in wild-type and MHC^403/+ mice indicates independent cardiac remodeling pathways and predicts that coexistent hypertension and HCM should not profoundly exacerbate cardiac hypertrophy. In contrast, sarcomere mutation and cyclosporin A-mediated calcineurin inhibition stimulate a shared hypertrophic signaling pathway. Defining distinct signaling pathways that trigger myocyte growth should help to tailor therapies for cardiac hypertrophy.

Key Words: hypertrophy • cardiomyopathy • hypertension • genetics • signal transduction

This article has been cited by other articles:

				B. M. Palmer, Y. Wang, P. Teekakirikul, J. T. Hinson, D. Fatkin, S. Strouse, P. VanBuren, C. E. Seidman, J. G. Seidman, and D. W. Maughan Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1939 - H1947. [Abstract] [Full Text] [PDF]

				C. J. Barrick, M. Rojas, R. Schoonhoven, S. S. Smyth, and D. W. Threadgill Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2119 - H2130. [Abstract] [Full Text] [PDF]

				S. Brickson, D. P. Fitzsimons, L. Pereira, T. Hacker, H. Valdivia, and R. L. Moss In vivo left ventricular functional capacity is compromised in cMyBP-C null mice Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1747 - H1754. [Abstract] [Full Text] [PDF]

				K. E. Merten, Y. Jiang, W. Feng, and Y. J. Kang Calcineurin Activation Is Not Necessary for Doxorubicin-Induced Hypertrophy in H9c2 Embryonic Rat Cardiac Cells: Involvement of the Phosphoinositide 3-Kinase-Akt Pathway J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 934 - 940. [Abstract] [Full Text] [PDF]

				D. Stilli, L. Bocchi, R. Berni, M. Zaniboni, F. Cacciani, C. Chaponnier, E. Musso, G. Gabbiani, and S. Clement Correlation of {alpha}-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats Exp Physiol, May 1, 2006; 91(3): 571 - 580. [Abstract] [Full Text] [PDF]

				B. A. Rothermel, K. Berenji, P. Tannous, W. Kutschke, A. Dey, B. Nolan, K.-D. Yoo, E. Demetroulis, M. Gimbel, B. Cabuay, et al. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure Physiol Genomics, September 21, 2005; 23(1): 18 - 27. [Abstract] [Full Text] [PDF]

				G. de Simone, S. R. Daniels, T. R. Kimball, M. J. Roman, C. Romano, M. Chinali, M. Galderisi, and R. B. Devereux Evaluation of Concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation Hypertension, January 1, 2005; 45(1): 64 - 68. [Abstract] [Full Text] [PDF]

				T. S. Kato, A. Noda, H. Izawa, A. Yamada, K. Obata, K. Nagata, M. Iwase, T. Murohara, and M. Yokota Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography Circulation, December 21, 2004; 110(25): 3808 - 3814. [Abstract] [Full Text] [PDF]

				A. H. Maass, K. Ikeda, S. Oberdorf-Maass, S. K.G. Maier, and L. A. Leinwand Hypertrophy, Fibrosis, and Sudden Cardiac Death in Response to Pathological Stimuli in Mice With Mutations in Cardiac Troponin T Circulation, October 12, 2004; 110(15): 2102 - 2109. [Abstract] [Full Text] [PDF]

				B. M. Palmer, D. E. Fishbaugher, J. P. Schmitt, Y. Wang, N. R. Alpert, C. E. Seidman, J. G. Seidman, P. VanBuren, and D. W. Maughan Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H91 - H99. [Abstract] [Full Text] [PDF]

				G. de Simone Concentric or Eccentric Hypertrophy: How Clinically Relevant Is the Difference? Hypertension, April 1, 2004; 43(4): 714 - 715. [Full Text] [PDF]